Free Trial
→ Bank of America: 'Digital Dollar Inevitable' (From Decentralized Masters) (Ad)tc pixel
OTCMKTS:NVZMF

Novozymes A/S Earnings Date & Estimates

Novozymes A/S logo
$68.70 0.00 (0.00%)
As of 10/30/2026

Novozymes A/S is estimated to report earnings on Thursday, November 5, 2026, before market opens.

Research:Profile

Upcoming Earnings Announcement

Announcement Date
Time
Before Market Opens
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Novozymes A/S

Novozymes A/S is expected to post earnings of $0.7480 per share on revenue of $1.29 billion. Novozymes A/S last reported on April 20, 2016, posting $0.3710 per share and missing the $2.43 consensus estimate. Novozymes A/S has beaten the consensus EPS estimate in 2 of its last 4 quarters.

Consensus Estimates

Consensus EPS
$0.7480
Expected Revenue
$1.29 billion

Recent Track Record

Last Reported
Q1
Last Quarter EPS
$0.3710 (Missed by -$2.0590)
EPS Beat Rate
2 of last 4 quarters

Prepare for the Earnings Call

Novozymes A/S Earnings FAQ

Novozymes A/S (OTCMKTS:NVZMF) is estimated to report earnings on Thursday, November 5, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect Novozymes A/S to post earnings of $0.7480 per share for the quarter.

The consensus revenue estimate for Novozymes A/S is $1.29 billion for the quarter.

Novozymes A/S Earnings Headlines

Novonesis (Novozymes) B Class B NVZMF
July 3, 2026  |  morningstar.comM
Novonesis (Novozymes A/S): Interim report Q1 2026
May 5, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-05/68393410-novonesis-novozymes-a-s-interim-report-q1-2026-399.htm
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
November 3 at 1:00 AM  |  Porter & Company (Ad)
Novonesis (Novozymes A/S): Novonesis expands global footprint with acquisition of production facility in Southeast Asia
April 8, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-04/68143353-novonesis-novozymes-a-s-novonesis-expands-global-footprint-with-acquisition-of-production-facility-in-southeast-asia-399.htm
Novozymes (CPSE:NSIS B): Assessing Valuation After Upward Sales Growth Guidance and Improved Q3 Results
November 12, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/novozymes-cpse-nsis-b-assessing-181100745.html
Could Gut Microbiome Research Shift Novozymes' Innovation Narrative in Health and Nutrition (CPSE:NSIS B)?
September 8, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/could-gut-microbiome-research-shift-135041138.html
See More Novozymes A/S Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Novozymes A/S? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Novozymes A/S and other key companies, straight to your email.

About Novozymes A/S

Novozymes A/S (OTCMKTS:NVZMF) was a Denmark-based biotechnology company specializing in enzymes and microorganisms for industrial, agricultural, and consumer applications. Its technologies were designed to help customers improve production efficiency, reduce resource use, and develop more sustainable products and processes.

The company developed and marketed enzyme and microbial solutions for industries including food and beverages, household care, agriculture, bioenergy, animal health, and industrial manufacturing. Its products supported applications such as baking, brewing, detergents, textile processing, crop production, animal feed, and the conversion of biomass into renewable fuels and other materials.

Novozymes served customers across global markets through research, production, and commercial operations in multiple regions. The company was established in 2000 through the separation of the enzyme business from Novo Nordisk. In 2024, Novozymes combined with Chr. Hansen Holding A/S to form Novonesis, and Novozymes ceased operating as a standalone company under its former name.

View Novozymes A/S Profile
Earnings Tools